XTAETPGM
Market cap206mUSD
Dec 24, Last price
699.10ILS
1D
0.49%
1Q
12.40%
IPO
38.44%
Name
Top Gum Industries Ltd
Chart & Performance
P/E
6,453.93
P/S
454.78
EPS
0.03
Div Yield, %
0.00%
Shrs. gr., 5y
0.76%
Rev. gr., 5y
26.51%
Revenues
46m
+3.84%
Net income
3m
-11.56%
CFO
1m
+34.11%
Earnings
Feb 14, 2025
Profile
TopGum Industries Ltd. develops, manufactures, and markets dietary and nutraceutical gummies. The company offers a range of gummiceutical supplements that include vitamins, minerals, natural extracts, pre and probiotics, and food products; and nutraceutical products. It also imports and markets other sweets. The company was incorporated in 2004 and is based in Sderot, Israel.
IPO date
Aug 12, 2021
Employees
150
Domiciled in
IL
Incorporated in
IL
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | |
| Income | ||||||
Revenues | 45,597 3.84% | 43,911 32.77% | 33,073 29.21% | |||
Cost of revenue | 43,070 | 35,311 | 27,065 | |||
Unusual Expense (Income) | ||||||
NOPBT | 2,527 | 8,600 | 6,008 | |||
NOPBT Margin | 5.54% | 19.59% | 18.17% | |||
Operating Taxes | 757 | 677 | 223 | |||
Tax Rate | 29.96% | 7.87% | 3.71% | |||
NOPAT | 1,770 | 7,923 | 5,785 | |||
Net income | 3,213 -11.56% | 3,633 129.79% | 1,581 104.26% | |||
Dividends | ||||||
Dividend yield | ||||||
Proceeds from repurchase of equity | 17,620 | 63 | 28,638 | |||
BB yield | -3.05% | -0.01% | -3.82% | |||
| Debt | ||||||
Debt current | 1,186 | 2,004 | 688 | |||
Long-term debt | 31,502 | 13,038 | 4,118 | |||
Deferred revenue | ||||||
Other long-term liabilities | 463 | 211 | 333 | |||
Net debt | 20,577 | 11,004 | (13,125) | |||
| Cash flow | ||||||
Cash from operating activities | 1,443 | 1,076 | 1,095 | |||
CAPEX | (26,591) | (13,260) | (7,579) | |||
Cash from investing activities | (28,224) | (13,398) | (7,509) | |||
Cash from financing activities | 33,203 | 263 | 22,123 | |||
FCF | (28,127) | (9,879) | (4,027) | |||
| Balance | ||||||
Cash | 12,111 | 4,327 | 17,931 | |||
Long term investments | (289) | |||||
Excess cash | 9,831 | 1,842 | 16,277 | |||
Stockholders' equity | 11,411 | 7,836 | 7,751 | |||
Invested Capital | 83,282 | 52,637 | 42,425 | |||
ROIC | 2.60% | 16.67% | 17.62% | |||
ROCE | 2.71% | 15.74% | 11.97% | |||
| EV | ||||||
Common stock shares outstanding | 97,657 | 96,473 | 83,216 | |||
Price | 5.92 4.39% | 5.68 -37.06% | 9.02 | |||
Market cap | 578,520 5.67% | 547,484 -27.03% | 750,275 | |||
EV | 599,097 | 559,813 | 737,150 | |||
EBITDA | 4,594 | 10,543 | 7,858 | |||
EV/EBITDA | 130.41 | 53.10 | 93.81 | |||
Interest | 235 | 137 | 262 | |||
Interest/NOPBT | 9.30% | 1.59% | 4.36% | |||